Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 062750

Expand all

PIPRACIL (PIPERACILLIN SODIUM)
EQ 2GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PIPERACILLIN SODIUM
Proprietary Name: PIPRACIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062750
Product Number: 001
Approval Date: Oct 13, 1987
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PIPRACIL (PIPERACILLIN SODIUM)
EQ 3GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PIPERACILLIN SODIUM
Proprietary Name: PIPRACIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062750
Product Number: 002
Approval Date: Oct 13, 1987
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PIPRACIL (PIPERACILLIN SODIUM)
EQ 4GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: PIPERACILLIN SODIUM
Proprietary Name: PIPRACIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062750
Product Number: 003
Approval Date: Oct 13, 1987
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information